Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지

소아 비만증에서 비알코올성 지방간염의 유병률

Prevalence of the Nonalcoholic Fatty Liver Disease in Obese Children

  • 황성욱 (연세대학교 의과대학 소아과학교실) ;
  • 김덕희 (연세대학교 의과대학 소아과학교실) ;
  • 김호성 (연세대학교 의과대학 소아과학교실)
  • Hwang, Sung Woog (Department of Pediatrics, Yonsei University College of Medicine) ;
  • Kim, Duk Hee (Department of Pediatrics, Yonsei University College of Medicine) ;
  • Kim, Ho Seong (Department of Pediatrics, Yonsei University College of Medicine)
  • 투고 : 2004.08.13
  • 심사 : 2004.09.20
  • 발행 : 2005.01.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

목 적 : 비만증은 대사성증후군과 더불어 비알코올성 지방간염과 밀접한 관계가 있다. 본 연구는 비만증으로 진단된 학생을 대상으로 비알코올성 지방간염 및 그에 관련된 인자를 알아보고자 하였다. 방 법 : 초 중학교 신체검사상 체질량지수 95 백분위수 이상의 비만아 중 279명을 대상으로 설문지, 신체계측, 혈액검사, 복부지방 초음파 검사를 실시하였다. 결 과 : 전체 연구 대상자 279명 중 비알코올성 지방간염이 있는 사람은 27명으로 9.7%였다. 이중 비만도 30% 이하인 경도비만아 135명 중 5명(3.7%)에서 비알코올성 지방간염이 나타났으며 비만도 30% 이상인 중증도 이상의 비만아에서 비알코올성 지방간염의 유병률은 144명 중 22명(15.2%)으로 비만정도가 심할수록 지방간염의 유병률은 증가하였다. 또한 대사성증후군과 밀접한 연관성이 있다고 알려진 복부 내장지방두께와 허리/엉덩이 둘레비가 클수록 비알코올성 지방간염이 잘 반영되는 것으로 나타났다. 결 론 : 본 연구의 결과는 소아 비만아에서 비알코올성 지방간염의 유병률은 9.7%였으며 비만정도가 심할수록 비알코올성 지방간염의 유병률은 증가하였다. 또한 대사성 증후군의 구성인자와 비알코올성 지방간염은 상당한 연관성이 있으며 이들의 공통적인 특징인 인슐린 저항성의 지표는 치료효과 판정 및 통합적인 위험인자 관리에 도움이 될 것이라 생각된다.

Purpose : Obesity is, along with metabolic syndrome, closely related with nonalcoholic fatty liver disease. This study tried to evaluate the prevalence of nonalcoholic liver disease in obese children and verify the factors associated with the disease. Methods : Two hundred and seventy nine children who showed a body mass index of 95 percentile over the baseline in health examinations of surrounding schools were evaluated. Questionnaires, body measurements, blood examinations, and ultrasonographic measurements of abdominal fat were examined. Results : Out of 279 children enrolled for the study, 27 children were found to possess nonalcoholic liver disease(9.7%). Among those found to be positive for nonalcoholic liver disease, it's prevalence increased to 15.2%(22 out of 144 children) among children with severe obesity. Factors known to be involved with metabolic syndrome, namely waist/hip circumference ratio and thickness of abdominal fat, were found to be closely related to nonalcoholic fatty liver as well. Conclusion : The prevalence of nonalcoholic fatty liver in obese children was 9.7%, with higher incidence observable in severer obesity. Factors responsible for metabolic syndrome were closely associated with nonalcoholic fatty liver disease, and the level of insulin resistance, which is an useful index in both diseases, can be utilized in evaluation of the effect of treatment and control of risk factors.

키워드

과제정보

연구 과제 주관 기관 : 보건복지부

참고문헌

  1. Hoyumpa AM Jr, Greene HL, Dunn GD, Schencker S. Fatty liver : biochemical and clinical considerations. Am J Dig Dis 1975;20:1142-70 https://doi.org/10.1007/BF01070758
  2. Yu AS, Keeffe EB. Nonalcohoic fatty liver disease. Rev Gastroenterol Disord 2002;2:11-9
  3. Contos MJ, Sanyal AJ. The clinicopathologic spectrum and management of nonalcoholic fatty liver disease. Adv Anat Pathol 2002;9:37-51 https://doi.org/10.1097/00125480-200201000-00005
  4. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment : insulin resistance and B-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28:412-9 https://doi.org/10.1007/BF00280883
  5. Hrebicek J, Janout V, Malincikova J, Horakovaj D, Cizek L. Detection of insulin resistance by simple quantitative insulin sensitivity check index for epidemiological assessment and prevention. J Clin Endocrinol Metab 2002;87:144-7 https://doi.org/10.1210/jc.87.1.144
  6. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31 https://doi.org/10.1056/NEJMra011775
  7. Cortez-Pinto H, Camilo ME, Baptista A, De Oliveria AG, De Moura MC. Non-alcoholic fatty liver : another feature of the metabolic syndrome? Clin Nutr 1999;18:353-8 https://doi.org/10.1016/S0261-5614(99)80015-6
  8. McCullough AJ. Update on nonalcoholic fatty liver disease. J clin Gastroenterol 2002;34:255-62 https://doi.org/10.1097/00004836-200203000-00013
  9. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis : Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8
  10. Falck-Ytter Y, Younossi ZM, Marchesini G, MaCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001;21:17-26 https://doi.org/10.1055/s-2001-12926
  11. Clark JM, Brancati FL, Diehl AE. Nonalcoholic fatty liver disease : the most common cause of abnormal liver enzymes in the U.S. population[abstract]. Gastroenterology 2001;120:A-65.
  12. Wanless IR, Lentz JS. Fatty liver hepatitis(steatohepatitis) and obesity : an autopsy study with analysis of risk factors. Hepatology 1990;12:1106-10 https://doi.org/10.1002/hep.1840120505
  13. Day C, James O. Steatohepatitis : A tale of two 'hits'? Gastroenterology 1998;114:842-5 https://doi.org/10.1016/S0016-5085(98)70599-2
  14. Harrison SA, Kadakia S, Lang KA, Schenker S. Nonalcoholic steatohepatitis : What we know in the new millennium. Am J Gastroenterol 2001;97:2714-24
  15. Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003;143:500-5 https://doi.org/10.1067/S0022-3476(03)00325-1
  16. Chitturi S, Weltman M, Farrell GC, McDonald D, Liddle C, samarasinghe D, et al. HFE mutations, hepatic iron, and fibrosis : ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology 2002;36:142-9 https://doi.org/10.1053/jhep.2002.33892
  17. Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease : pathogenesis and the role of antioxidants. Nutr Rev 2002;60:289-93 https://doi.org/10.1301/002966402320387224
  18. Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K. in situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver disease. J Hepatol 2002;37:56-62 https://doi.org/10.1016/S0168-8278(02)00073-9
  19. Baffy G, Zhang CY, Glickman JN, Lowell BB. Obesityrelated fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2. Hepatology 2002;35:753-61 https://doi.org/10.1053/jhep.2002.32028
  20. Diehl AM. Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol Gastrointest Liver Physiol 2002;282:G1-5
  21. Kaplan LM. Leptin, obesity, and liver disease. Gastroenterology 1998;115:997-1001 https://doi.org/10.1016/S0016-5085(98)70272-0
  22. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991;43:26-31 https://doi.org/10.1016/S0009-9260(05)80350-2
  23. Caturelli E, Squillatne MM, Andriulli A, Rapaccini GL. Hypoechoic lesions in the 'bright liver' : A reliable indicator of fatty change. A prospective study. J Gastroenterol Hepatol 1992;7:469-72 https://doi.org/10.1111/j.1440-1746.1992.tb01022.x
  24. Foster KJ, Dewbury KC, Griffith AH. The accuracy of ultrasound in detection of fatty infiltration of the liver. Br J Radiology 1980;53:440-2 https://doi.org/10.1259/0007-1285-53-629-440
  25. Sakugawa H, Nakayoshi T, Kobashigawa K, Nakasone H, Kawakami Y, Yamashiro T, et al. Alanine aminotransferase elevation not associated with fatty liver is frequently seen in obese japanese women. Eur J Clin Nutr 2004;58:1-5 https://doi.org/10.1038/sj.ejcn.1601736
  26. Park HS, Shin ES, Kim MW, Kim KM. Improvement of liver function by weight control in children with fatty liver. Korean J Nutrition 1995;28:629-35
  27. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003;98:955-6 https://doi.org/10.1111/j.1572-0241.2003.07485.x
  28. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-62 https://doi.org/10.1002/hep.510300604
  29. George DK, Goldwurm S, Macdonald GA, Cowley LL, Walker NI, Ward PJ, et al. Increased hepatid iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998;114:311-8 https://doi.org/10.1016/S0016-5085(98)70482-2
  30. Tornaghi G, Raiteri R, Pozzato C, Rispoli A, Bramani M, Cipolat M, et al. Anthropometric or ultrasonic measurements in assessment of visceral fat? : a comparative study. Int J Obes Relat Metab Disord 1994;18:771-5
  31. Kim SK, Kim SH, Rhee YM, Choi SH, Cho YL, Ahn CW, et al. The comparison of intra-abdominal fat distance and visceral adipose tissue area or visceral fat to skeletal muscle area ratio measured by computed tomography. Korean Journal of Medicine 2003;64:49-59
  32. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitiative insulin sensitivity check index : a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10 https://doi.org/10.1210/jc.85.7.2402
  33. Sung YK, choi WH, Lee CB, Park YS. Insulin resistance measured by QUICKI and obesity in type 2 diabetic patients. Journal of Korean Society for the Study of Obesity 2003;12:162-72
  34. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease : A spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-9
  35. Sanyal AJ. Nonalcoholic steatohepatitis. Clin Perspect Gastroenterol 2000;3:129-39
  36. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease : predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121: 91-100 https://doi.org/10.1053/gast.2001.25540
  37. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, et al. Liver fibrosis in overweight patients. Gastroenterology 2000;118:1117-23 https://doi.org/10.1016/S0016-5085(00)70364-7
  38. Kim WR, Poterucha JJ, Porayko MK, Dickson ER, Steers JL, Wiesner RH. Recurrence of nonalcoholic steatohepatitis following liver transplantation. Transplantation 1996;62:1802 https://doi.org/10.1097/00007890-199612270-00021
  39. Laurin J, Lindor KD, Crippin JS, Gossard A, Gores GJ, Ludwig J, et al. Ursodeoxycholic acid or clofibrate in the treatment of nonalcoholic induced steatohepatitis : a pilot study. Hepatology 1996;23:74-80
  40. Agrawal S, Bonkovsky H. Management of nonalcoholic steatohepatitis : an analytic review. J Clin Gastroenterol 2002;35:253-61 https://doi.org/10.1097/00004836-200209000-00011
  41. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver disease : prospective cohort study. BMJ 2004;328:983 https://doi.org/10.1136/bmj.38050.593634.63